Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Central muscarinic receptor agonists patented by U. of Toledo

Dec. 7, 1998

Zomig copromoted by Cephalon in the U.K.

Dec. 4, 1998

Heterocyclic melatonergic agents designed at ADIR

Dec. 4, 1998

Harris FRC establishes safety of candidate antiepileptic drug in volunteer studies

Dec. 3, 1998

Final marketing application filed for Ampligen in E.U.

Dec. 3, 1998

Significant protection against ischemic injury in cortex of rats primed with estradiol

Dec. 3, 1998

Gene therapies for neuromuscular diseases pursued by Transgene and AFM

Dec. 2, 1998

ABS receives funding from NIH to support development of Alzheimer's drug

Dec. 1, 1998

Piperidine derivatives from Sanofi useful for neurokinin-dependent pathologies

Dec. 1, 1998

Orion launches entacapone in first markets and updates safety information

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.